Delcath Systems Inc (DCTH)

[Rapture2020]

Fun Fact: Which of the four DCTH 2018 PR's about presenting at Conferences is different than the other three? (hint: #4).


1. Delcath to Present at 30th Annual Roth Conference. Jennifer K. Simpson, Ph.D., MSN, CRNP, President and Chief Executive Officer of Delcathwill present at the Roth Capital Partners 30th Annual Conference on Tuesday March 13, 2018 at 1:30pm Pacific Time. Dr. Simpson will highlight the recent corporate developments and provide an overview of the Company.

2. Delcath to Present at Oppenheimer 28th Annual Healthcare Conference. Jennifer K. Simpson, Ph.D., MSN, CRNP, President and Chief Executive Officer of Delcathwill present at the Oppenheimer 28th Annual Healthcare Conference on Wednesday March 21, 2018 at 3:55pm Eastern Time. Dr. Simpson will highlight the recent corporate developments and provide an overview of the Company.


3. Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference. Jennifer K. Simpson, Ph.D., MSN, CRNP, President and Chief Executive Officer of Delcath, will present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference being held May 8-9, 2018 at Reed Smith, LLP in New York.

4. Delcath Systems to Present at the 8th Annual LD Micro Invitational. Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that it will be presenting at the 8th Annual LD Micro Invitational on Monday, June 4 at 12:00pm PST / 3:00pm EST. Jennifer K. Simpson, PhD, MSN, CRNP, President and Chief Executive Officer of Delcath Systems, will be presenting and meeting with investors.


Oh, and for what it’s worth, per Fintel, SEC Form 13F-HR’s were filed by Gemmer Asset Management (5.11.18) and QCI Asset Management (5.3.18). DCTH Institutional owners up to 5, though it is not clear how much they own.

https://fintel.io/so/us/dcth

Happy Monday.